Literature DB >> 25537957

Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.

Andrew A Taitano1, Michael Markow, Jon E Finan, Donald E Wheeler, John Paul Gonzalvo, Michel M Murr.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is prevalent in obese patients. We sought to determine the effects of bariatric surgery on the histological features of NAFLD. Two blinded pathologists graded liver biopsies done during bariatric procedures and subsequent operations in 160 patients using the Brunt classification. Data are mean ± SD. Interval between biopsies was 31 ± 26 months. Initial biopsies demonstrated steatosis 77 %, lobular inflammation 39 %, and chronic portal inflammation 56 %. Steatohepatitis was present in 27 %. Grade 2-3 fibrosis was present in 27 %, and cirrhosis was present in one patient. On post-bariatric biopsy, steatosis resolved in 75 %, lobular inflammation resolved in 75 %, chronic portal inflammation resolved in 49 %, and steatohepatitis resolved in 90 %. Fibrosis of any grade resolved in 53 % and improved in another 3 % of patients. Grade 2 fibrosis resolved in 58 %, improved in 3 %, and did not worsen in 11 %. Bridging fibrosis resolved in 29 %, improved in 29 %, and did not worsen in 29 %. Bariatric surgery is associated with resolution of steatosis or steatohepatitis in the majority of patients. More importantly, grade 2 or 3 (bridging) fibrosis is resolved or improved in 60 % of patients. Bariatric surgery should be considered as a treatment of NAFLD in severely obese patients.

Entities:  

Mesh:

Year:  2014        PMID: 25537957     DOI: 10.1007/s11605-014-2678-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

Review 1.  Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.

Authors:  Kapil Mehta; David H Van Thiel; Nikunj Shah; Sohrab Mobarhan
Journal:  Nutr Rev       Date:  2002-09       Impact factor: 7.110

2.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery.

Authors:  Constantine T Frantzides; Mark A Carlson; Ronald E Moore; John G Zografakis; Atul K Madan; Susan Puumala; Ali Keshavarzian
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

4.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

6.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

7.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

8.  Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.

Authors:  John G Kral; Swan N Thung; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Simon Marceau; Serge Simard; Picard Marceau
Journal:  Surgery       Date:  2004-01       Impact factor: 3.982

9.  Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Authors:  Xiuli Liu; Audrey J Lazenby; Ronald H Clements; Nirag Jhala; Gary A Abrams
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

10.  The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.

Authors:  Sherene Shalhub; Anna Parsee; Scott F Gallagher; Krista L Haines; Chris Willkomm; Stephen G Brantley; Haim Pinkas; Lisa Saff-Koche; Michel M Murr
Journal:  Obes Surg       Date:  2004-01       Impact factor: 4.129

View more
  39 in total

Review 1.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

2.  Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection.

Authors:  Ming-Lun Han; Wei-Jei Lee; Jung-Chien Chen; Kong-Han Ser; Shu-Chun Chen; Yi-Chih Lee
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

Review 3.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 5.  Gastric Bypass and Influence on Improvement of NAFLD.

Authors:  Vamsi Alli; Ann M Rogers
Journal:  Curr Gastroenterol Rep       Date:  2017-06

6.  Treatment of NASH: What Helps Beyond Weight Loss?

Authors:  Bubu A Banini; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2017-04-11       Impact factor: 10.864

7.  Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Authors:  Laísa Simakawa Jimenez; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; Murillo Pimentel Utrini; Martinho Antonio Gestic; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

8.  Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Arul Earnest; Paul E O'Brien; Wendy A Brown
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

9.  Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Joshua S Winder; Brandon S Dudeck; Sarayna Schock; Jerome R Lyn-Sue; Randy S Haluck; Ann M Rogers
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

10.  Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.

Authors:  Felix Nickel; Christian Tapking; Laura Benner; Janina Sollors; Adrian T Billeter; Hannes G Kenngott; Loay Bokhary; Mathias Schmid; Moritz von Frankenberg; Lars Fischer; Sebastian Mueller; Beat P Müller-Stich
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.